This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.93% per year. These returns cover a period from January 1, 1988 through October 6, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
L3Harris Beats Q3 Earnings Estimates, Raises '25 Revenue View
by Zacks Equity Research
LHX posts solid Q3 results with earnings and revenue beats across all segments and lifts its 2025 revenue outlook.
Huntington Ingalls Q3 Earnings Beat Estimates, Revenues Rise Y/Y
by Zacks Equity Research
HII's Q3 earnings and revenues beat estimates as all three business segments post double-digit growth.
Should You Buy Palantir Stock Ahead of Q3 Earnings Report?
by Shuvra Shankar Dey
PLTR's Q3 results loom as revenue and profit growth soar, but its soaring valuation may test investor patience.
Boeing's Q3 Earnings Miss Estimates, Revenues Increase Y/Y
by Zacks Equity Research
BA posts a wider Q3 loss despite a 30% revenue jump, due to higher jet deliveries and growth across all business segments.
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Investors Heavily Search RTX Corporation (RTX): Here is What You Need to Know
by Zacks Equity Research
Zacks.com users have recently been watching RTX (RTX) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Why RTX (RTX) is a Top Growth Stock for the Long-Term
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
General Dynamics' Q3 Earnings Surpass Estimates, Revenues Improve Y/Y
by Zacks Equity Research
GD posts strong Q3 results with EPS up 15.8% and revenues climbing 10.6%, fueled by Aerospace and Marine Systems growth.
Top Research Reports for Amazon.com, Wells Fargo & Amgen
by Mark Vickery
Amazon's AI push, Wells Fargo's post-cap growth, and Amgen's new drug momentum headline Zacks' latest top analyst reports.
Aerospace & Defense ETFs in Focus This Earnings Season
by Yashwardhan Jain
Strong Q3 earnings from Northrop Grumman, RTX and Lockheed Martin underscore the Aerospace & Defense sector's surge amid global tensions.
Honeywell's Q3 Earnings Top Estimates on Strong Aerospace Momentum
by Zacks Equity Research
HON beats Q3 earnings and revenue estimates, powered by strong aerospace gains and solid building automation growth.
Hexcel's Q3 Earnings Miss Estimates, Sales Beat, '25 EPS View Lowered
by Zacks Equity Research
HXL's Q3 earnings lag estimates despite a slight sales beat, as weaker aerospace demand and margin pressure lead to a lowered 2025 EPS outlook.
Textron Q3 Earnings Beat Estimates, Revenues Improve Y/Y
by Zacks Equity Research
TXT's Q3 earnings topped estimates despite a revenue miss, led by strong Aviation and Bell segment growth.
Teledyne's Q3 Earnings & Revenues Beat Estimates, Increase Y/Y
by Zacks Equity Research
TDY's Q3 earnings and sales outpace estimates, with strong gains in defense electronics driving solid year-over-year growth.
Company News for Oct 22, 2025
by Zacks Equity Research
Companies in The News Are: KO, DHR, RTX, VST
The Zacks Analyst Blog Highlights Lockheed Martin, Boeing, RTX, SHLD, ITA and PPA
by Zacks Equity Research
As the Gaza ceasefire falters, defense stocks like Lockheed Martin, Boeing, and RTX surge, putting ETFs ITA, PPA, and SHLD in focus.
Fragile Gaza Ceasefire Puts Defense ETFs in the Spotlight
by Aparajita Dutta
A fragile Gaza ceasefire and renewed violence are fueling investor demand for defense ETFs like ITA, SHLD and PPA.
Compared to Estimates, RTX (RTX) Q3 Earnings: A Look at Key Metrics
by Zacks Equity Research
While the top- and bottom-line numbers for RTX (RTX) give a sense of how the business performed in the quarter ended September 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
RTX Beats on Q3 Earnings & Revenues, Raises '25 EPS View
by Zacks Equity Research
RTX delivers strong Q3 results, with EPS and sales topping estimates and full-year guidance up on broad segment gains.
RTX (RTX) Q3 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
RTX (RTX) delivered earnings and revenue surprises of +19.72% and +4.64%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
The Zacks Analyst Blog Highlights AstraZeneca, RTX, Applied Materials, Park Aerospace and NetSol Technologies
by Zacks Equity Research
Zacks spotlights AstraZeneca, RTX, and Applied Materials for strong performance and growth potential, while microcap names Park Aerospace and NetSol Technologies show niche momentum.
The Zacks Analyst Blog Highlights Tesla, Netflix, Procter & Gamble, Coca-Cola, RTX and IBM
by Zacks Equity Research
Zacks highlights Tesla, Netflix, Procter & Gamble, Coca-Cola, RTX and IBM as global markets brace for a data-heavy week amid U.S. shutdown woes and renewed trade tensions.
Top Research Reports for AstraZeneca, RTX & Applied Materials
by Mark Vickery
AstraZeneca, RTX, and Applied Materials stand out in today's Zacks Research Daily with strong performance drivers and key growth catalysts.
Early Warning Signs Materialize: Global Week Ahead
by John Blank
The U.S. government shutdown extends into another week while Q3 earnings season is in full swing and U.S./China trade tensions remain tense.
RTX Invests $53M to Expand Facility for Advanced Missile Defense Radar
by Zacks Equity Research
RTX is investing $53M to expand its Andover facility, boosting production of next-gen radar systems to counter advanced missile threats.